Results 101 to 110 of about 19,509 (202)

COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To compare clinical efficacy and effect on endothelium function of original bisoprolol and its generic in patients with stable angina and concomitant chronic obstructive pulmonary disease (COPD).Material and methods.
N. Yu. Grigorieva   +2 more
doaj   +1 more source

Tolerability of Bisoprolol on Domiciliary Spirometry in COPD [PDF]

open access: yes, 2017
We investigated if serial domiciliary measures of spirometry were sensitive at detecting subtle effects of beta-2 blockade associated with bisoprolol in (n = 17) patients with COPD.
Lipworth, Brian J.   +3 more
core   +1 more source

Studi penggunaan bisoprolol pada pasien gagal jantung di Rumkital Dr. Ramelan Surabaya [PDF]

open access: yes, 2019
Gagal jantung merupakan sindroma klinis disebabkan oleh disfungsi sistolik atau disfungsi diastolik yang mengakibatkan ketidakmampuan jantung untuk memompa darah dalam jumlah yang cukup guna memenuhi kebutuhan tubuh.
Rahmanto, Sasmito Adi
core  

Spectrophotometric determination of bisoprolol in pharmaceutical preparations by charge transfer reactions

open access: yes, 2012
A simple, rapid and sensitive method for the spectrophotometric determination, of bisoprolol was developed. The proposed methods were based on the charge-transfer reactions of bisoprolol, as n-electron donor, with 7,7,8,8-tetracyanoqumodimethane (TCNQ ...
Kel, Elif, Ulu, Sevgi
core   +1 more source

EVALUASI KETEPATAN DOSIS BISOPROLOL PADA PASIEN RAWAT INAP DI RUMAH SAKIT ISLAM SULTAN AGUNG SEMARANG PERIODE 2018 [PDF]

open access: yes, 2020
Bisoprolol merupakan antagonis β-1-adrenoreseptor kardioselektif, yang mana secara selektif dan kompetitif dalam menghambat stimulasi katekolamin (adrenalin) reseptor β-1.
Hasani Furdiyanti, Nova   +2 more
core  

HPLC METHOD DEVELOPMENT FOR THE ANALYSIS OF BISOPROLOL IN COMBINED DOSAGE FORM CONTAINING BISOPROLOL AND ENALAPRIL AND IN VITRO DISSOLUTION STUDIED

open access: yes, 2019
Objective: A simple, rapid and reproducible HPLC method was developed for the determination of bisoprolol in experimental combined dosage forms containing bisoprolol and enalapril and for drug dissolution studies. Methods: A C18 column (Hi Qsil C18, 5 μm,
Abdel-Megied, Ahmed M.   +6 more
core  

Bisoprolol Therapy and The Risk of Erectile Dysfunction in Stable Coronary Artery Disease Patients

open access: yes, 2017
Background :Bisoprolol is an anti angina and ischemic therapy in patient with stable coronary artery disease (CAD). Moreover it can decrease mortality and rehospitalization rate up to 34 % and 28 %.
Hariawan, Hariadi   +2 more
core   +1 more source

Bisoprolol medications in a comparative study on effectiveness and tolerability of original agent and its generic in patients with mild to moderate arterial hypertension

open access: yesКардиоваскулярная терапия и профилактика, 2007
Aim. To study clinical equivalence of two bisoprolol medications (Concor ® and Bisogamma®) in patients with mild to moderate arterial hypertension (AH). Material and methods. The study included 32 AH patients (15 men, 17 women): 66 % with Stage I, and 34
S. Yu. Martsevich   +8 more
doaj  

Population Pharmacokinetic Analysis of Bisoprolol in Patients with Stable Coronary Artery Disease

open access: yes, 2018
© 2017, Springer International Publishing Switzerland. Background and objectives: Bisoprolol is a selective beta adrenergic antagonist commonly used in treatment of coronary artery disease (CAD).
Deljanin-Ilic M.   +8 more
core   +1 more source

Bisoprolol effectiveness in arterial hypertension and coronary heart disease

open access: yes, 1970
The authors review the current evidence on the effectiveness of a highly selective b-adrenoblocker bisoprolol in the treatment of arterial hypertension and/or coronary heart disease.
O. D. Ostroumova   +2 more
core  

Home - About - Disclaimer - Privacy